19970114
 FDA cleared 139 products in 1996, a record increase   The Wall Street Journal,  Jan 15, 1997  The FDA approved 139 new drugs and biological products in 1996, a record one-year jump of 63% in approvals. FDA spokesman Donald McLearn attributed the record-setting results to the Prescription Drug User Fee Act, under which drug manufacturers have been paying fees to the government to cover the cost of additional drug reviewers. The agency cleared 131 new drugs for marketing in 1996--up 60% from 1995.   
